The testis' function is to produce haploid germ cells necessary for reproduction. Here we have combined a genome-wide transcriptomics analysis with immunohistochemistry-based protein profiling to characterize the molecular components of the testis. Deep sequencing (RNA-Seq) of normal human testicular tissue from seven individuals was performed and compared with 26 other normal human tissue types. All 20 050 putative human genes were classified into categories based on expression patterns. The analysis shows that testis is the tissue with the most tissue-specific genes by far. More than 1000 genes show a testis-enriched expression pattern in testis when compared with all other analyzed tissues. Highly testis enriched genes were further characterized with respect to protein localization within the testis, such as spermatogonia, spermatocytes, spermatids, sperm, Sertoli cells and Leydig cells. Here we present an immunohistochemistry-based analysis, showing the localization of corresponding proteins in different cell types and various stages of spermatogenesis, for 62 genes expressed at .50-fold higher levels in testis when compared with other tissues. A large fraction of these genes were unexpectedly expressed in early stages of spermatogenesis. In conclusion, we have applied a genome-wide analysis to identify the human testis-specific proteome using transcriptomics and antibody-based protein profiling, providing lists of genes expressed in a tissue-enriched manner in the testis. The majority of these genes and proteins were previously poorly characterised in terms of localization and function, and our list provides an important starting point to increase our molecular understanding of human reproductive biology and disease.
Introduction
The main function of the testis is to produce haploid germ cells necessary for our reproduction. This is achieved through a process that requires high fidelity throughout the life of fertile males. Spermatogenesis is a stepwise and highly coordinated series of events that start in cells located in the basal region of the seminiferous duct, where selfrenewing spermatogonial stem cells mitotically divide into spermatogonia. After several rounds of mitosis, the spermatogonia develop into primary and secondary spermatocytes that divide by meiosis to form spermatids. The final stage of spermatogenesis occurs in the luminal region of the seminiferous duct where spermatids differentiate into sperm. The various phases of spermatogenesis are distinguishable due to the morphologically different cell types present at each stage, since each cell type being closely associated with a particular phase of spermatogenesis (Russell et al., 1990) . In addition to germ cells, the Sertoli cell is intimately involved in all stages of spermatogenesis. This somatic cell, which lies interspersed throughout the seminiferous duct, regulates both the development and the number and quality of spermatogenic cells (Griswold 1998) . Approximately 90% of the cell mass in the testis is occupied by seminiferous ducts. In addition to the generation of sperm, the testis is crucial for synthesis of androgens that are necessary for spermatogenesis but also play a key role in the development of male sex characteristics. The main production of androgens, primarily testosterone, is localized in the testicular Leydig cell.
The highly specialized functions, specific events and cell structure of the testis endow a uniqueness to this particular tissue type. Although spermatogenesis has been studied in depth and the different stages of sperm maturation have been well defined, a large fraction of the genes involved in the different stages are yet unknown. A detailed knowledge regarding the molecular repertoire of the different cell types in the testis is essential to understand the complex interaction under normal and pathological conditions. The development of gene expression profiling techniques has allowed for characterization of tissues with high resolution. Several previous studies, based on expressed sequence tags (ESTs) and various microarray studies, have identified an unusual and diverse set of genes expressed in testes. A large number of these genes were shown to be unique to spermatogenic cells in both mouse (Kerr et al., 1994; Hoog, 1995) and humans (Pawlak et al., 1995; Penttilä et al., 1995) . Studies using Next Generation Sequencing technology (RNA-Seq) have also been employed on testicular tissue. In a recent study, 10 different types of human normal tissues showed that a higher fraction of genes and more diverse mRNA populations (less dominance of a few highly expressed genes) were expressed in the testis when compared with other tissue types (Ramskö ld et al., 2009) . Although RNA-Seq and other gene expression profiling techniques offer several advantages (Mortazavi et al., 2008; Wang et al., 2009) , the acquired data from the transcriptomics analyses based on a heterogeneous tissue material does not provide information regarding the expression pattern of corresponding proteins, e.g. what particular cell types express a specific protein or in what subcellular compartment a specific protein is expressed.
Here we analyzed genes expressed in normal human testis and these data are compared with the transcriptome of 26 other human tissue and organ types based on recently published RNA-seq data (Fagerberg et al., 2014) . Using this approach we not only detected all genes expressed in the adult testis, but also identified genes enriched in the testis versus other organs and tissue types. In order to translate the mRNA expression data to protein levels and to determine cell type-specific expression, the proteins corresponding to the tissue-specific genes were studied using the immunohistochemistry images at the Human Protein Atlas (www.proteinatlas.org) (Uhlén et al., 2005 (Uhlén et al., , 2010 Pontén et al., 2011) . The testis-specific transcriptome and the identified cell type-specific proteins in normal human testis can serve as a starting point for further disease-specific research.
Materials and Methods

Patient characteristics
The tissue samples used for transcript profiling of human testis consisted of histologically normal tissue from surgical specimens, including testis from four patients with cancer (two seminoma (Patient 1, age 34 years and Patient 2, age 37 years), one embryonal cancer (Patient 3, age 26 years) and one atypical plasmocytoma (Patient 4, age 56 years), two patients with only scar tissue (Patient 5, age 62 years and Patient 6, age 50 years) and one patient with focal inflammation (Patient 7, age 34 years). The corresponding histology of each case is shown in Supplementary data, Fig. S1 .
Transcript profiling (RNA-Seq)
The use of human tissue samples was approved by the Uppsala Ethical Review Board (Ref # 2011/473) . Tissues samples, collected within the infrastructure of an established biobank, were embedded in Optimal Cutting Temperature (O.C.T.) compound and stored at 2808C. A hematoxylin-eosin-stained frozen section (4 mm) was prepared from each sample using a cryostat and the CryoJane w Tape-Transfer System (Instrumedics, St. Louis, MO, USA). Each slide was examined by a pathologist to ensure accurate tissue morphology. Three sections (10 mm) were cut from each frozen tissue block and homogenized prior to extraction of total RNA, using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
The extracted RNA samples were analyzed using either an Agilent 2100 Bioanalyzer system (Agilent Biotechnologies, Palo Alto, USA) with the RNA 6000 Nano Labchip Kit or an Experion automated electrophoresis system (Bio-Rad Laboratories, Hercules, CA, USA) with the standard-sensitivity RNA chip. Only samples of high-quality RNA (RNA Integrity Number ≥7.5) were used in the following mRNA sample preparation for sequencing. mRNA sequencing was performed on Illumina HiSeq2000 and 2500 machines (Illumina, San Diego, CA, USA) using the standard Illumina RNA-Seq protocol with a read length of 2 × 100 bases.
Analysis of data
The raw reads from 20 050 transcripts obtained from the sequencing system were trimmed for low-quality ends with the software Sickle, using a phred quality threshold of 20. All reads shorter than 54 bp after the trimming were discarded. The processed reads were mapped to the GRCh37 version of the human genome with Tophat v2.0.3 (Trapnell et al., 2010) . Potential PCR duplicates were eliminated by applying the MarkDuplicates module of Picard 1.77. To obtain quantification scores for all human genes, FPKM (fragments per kilobase of exon model per million mapped reads) values were calculated with Cufflinks v2.0.2 (Trapnell et al., 2010) , which corrects for transcript length and the total number of mapped reads from the library to compensate for different read depths for different samples. The gene models from Ensembl build 69 (Flicek et al., 2012) were used in Cufflinks. In addition to Cufflinks, HTSeq v0.5.1 was run to calculate read counts for each gene, which were used for analyses of differentially expressed genes utilizing the DESeq package (Anders and Huber 2010; Flicek et al., 2012) . All data were analyzed with R Statistical Environment (RCoreTeam 2013) with the addition of the package 'gplots'. A network analysis was performed using Cytoscape 3.0 (Shannon et al., 2003) . For analyses performed in this study where a log2-scale of the data was used, pseudo-counts of +1 were added to the data set.
Specificity classification
The average FPKM value of all individual samples for each tissue was used to estimate the gene expression level. A cutoff value of 1 FPKM was used as the detection limit. Each of the 20 050 gene transcripts were classified into one of eight categories based on the FPKM levels: (i) 'Not detected'-,1 FPKM in testis; (ii) 'highly testis enriched'-50-fold higher FPKM level in testis compared with all other tissues; (iii) 'moderately testis enriched'-5-fold higher FPKM level in testis compared with all other tissues; (iv) 'group enriched'-5-fold higher average FPKM level in a group of 2 -7 tissues including testis compared with all other tissues; (v) 'expressed in all low'-detected in 27 tissues and at least one tissue ,10 FPKM; (vi) 'expressed in all high'-detected in 27 tissues and all tissues .10 FPKM; (vii) 'testis enhanced'-5-fold higher FPKM level in testis compared with the average FPKM value of all 27 tissues; (viii) 'mixed'-genes expressed in 1 -26 tissues and in none of the above categories. The 'testis-specific score' was defined as the Testis FPKM divided by the maximum FPKM value in any of the other 26 tissues.
Hierarchical clustering
FPKM values for all 20 050 genes were used to calculate a correlation matrix based on Spearman's rank correlation coefficient for each pairwise combination of individual samples (n ¼ 7). The correlation matrix was used for unsupervised hierarchical clustering analyses of individual samples using the average linkage method to measure distances between clusters. The results were visualized in a heatmap of all pairwise correlation coefficients.
The human testis-specific proteome Gene ontology analysis A gene ontology (GO) analysis (Ashburner et al., 2000) was performed using the GOrilla tool (Eden et al., 2009) in order to determine overrepresented GO categories in the gene set of tissue-enriched genes. For the cellular component analysis the GOSlim GOA associations were used to determine whether genes were extracellular, intracellular or membrane bound. The number of genes for each term was counted, allowing a gene to be associated with more than one term. A list of all genes analyzed in this study was used as the background list in GOrilla.
Tissue profiling
Tissue microarrays (TMAs) were generated as previously described (Kampf et al., 2012) , containing 1 mm cores of 46 different normal tissues in triplicates and 216 cancer tissues, representing the 20 most common cancers (Pontén et al., 2008) . The samples were received from the Department of Pathology, Uppsala University Hospital, Sweden, approved by the Research Ethics Committee at Uppsala University (Ref # Ups 02 -577). The immunohistochemical (IHC) staining was performed as previously described (Kampf et al., 2012) . In brief, 4 mm sections of the TMA blocks were cut and mounted on adhesive slides, baked at 608C for 45 min, followed by deparaffinization in xylene and hydration in graded alcohols. Blocking for endogenous peroxidase was performed in 0.3% hydrogen peroxide, and for antigen retrieval, a pressure boiler (Decloaking Chamber, Biocare Medical, Walnut Creek, CA, USA) was used, boiling the slides for 4 min at 1258C in Citrate buffer, pH 6 (Lab Vision, Freemont, CA, USA). Automated immunohistochemistry was performed using an Autostainer 480 instrument w (Lab Vision). Primary antibodies diluted in UltraAb Diluent w (Lab Vision) and the secondary reagent UltraVision LP HRP polymer w (Lab Vision) were incubated for 30 min each at room temperature (RT). The slides were developed for 10 min at RT, adding Diaminobenzidine (Lab Vision) as chromogen, followed by counterstaining with Mayers hematoxylin (Histolab) and mounting with Pertex w (Histolab). The immunohistochemically stained and mounted slides were scanned using an Aperio ScanScope XT Slide Scanner (Aperio Technologies, Vista, CA, USA) for generation of high-resolution digital whole slide images, followed by annotation by certified pathologists. In brief, the manual score of IHC-based protein expression was determined as the fraction of positive cells defined in different tissues: 0 ¼ 0 -1%, 1 ¼ 2 -25%, 2 ¼ 26 -75%, 3.75% and intensity of immunoreactivity: 0 ¼ negative, 1 ¼ weak, 2 ¼ moderate and 3 ¼ strong staining. All of the tissues used as donor blocks were acquired from the archives at the Department of Pathology of Uppsala University Hospital in agreement with approval from the Research Ethics Committee at Uppsala University (Ref # Ups 02-577).
All annotation data together with validation of the antibodies is publically available at the website www.proteinatlas.org (Uhlen et al., 2010; Pontén et al., 2011) , with the current version containing protein expression profiles from 21 984 antibodies, corresponding to 16 621 genes. 
Data availability
All the data (FPKM values for all the samples) will be available for downloads without any restrictions (www.proteinatlas.org/about/download). The primary data (reads) are available through the Array Express Archive (www. ebi.ac.uk/arrayexpress/) under the accession number: E-MTAB-1733. The transcript profiling data (FPKM values) for each gene in each cell and tissue will also be available in the next version of the Human Protein Atlas (www. proteinatlas.org).
Results
The transcriptomic analysis of testicular tissue
The transcriptomes of 27 different human organ-and tissue-types were analyzed using next generation sequencing (RNA-Seq) based on specimens from altogether 95 individuals (Fagerberg et al., 2014) . The normalized mRNA levels were determined for each sample, calculated as FPKM values where 1 FPKM roughly corresponds to one mRNA molecule per average cell in the sample (Hebenstreit et al., 2011) . Testicular tissues from seven individuals (age 26-62 years) were included in the analysis. Microscopical evaluation of cryosections showed normal appearing testicular tissue with intact spermatogenesis, with only rare inflammation and without contamination of tumor cells (Supplementary data, Fig. S1 ).
A total of 15 224 genes were detected in testis, with a mean expression value of .1 FPKM (with a variation from 15 397 genes in individual 2 to 15 039 genes in individual 3). Approximately 77% of all putative protein coding genes (n ¼ 20 050) were detected in testis and of the 27 different tissues analyzed, the testis had the largest number of detected genes.
The distribution of the genes detected in testis ranged from the maximum of 4956 FPKM (the mitochondrially encoded cytochrome c oxidase III gene) down to 1 FPKM to give a dynamic range of 5000. The 30 genes with the highest levels of expression in the testis are listed in Supplementary data, Table SI , which shows that a majority of these genes are those with 'house-keeping' functions, such as genes coding for mitochondrial and ribosomal proteins.
Analysis of the biological variation between the seven individual testis samples was performed for the expression levels of all the protein-coding genes in pairwise correlation plots and hierarchical clustering analysis. The correlation overall was high with Spearman's coefficients from 0.99 (Fig. 1A ) to 0.91 (Fig. 1B) . The average correlation coefficient for all the seven testis samples was 0.96 (Supplementary data, Table S2 , Supplementary data, Fig. S2 ). These results demonstrate high technical reproducibility between the testis samples, but also show low interindividual variation across the genome-wide expression pattern, although variations due to isoform differences of the transcripts cannot be ruled out.
As expected, similar comparisons between testis and other tissue types show a higher degree of variation. The comparison of the testis samples with data from the other 26 tissue types shows that the tissue with the highest similarity to testis was the ovary with a Spearman coefficient of 0.75 (Fig. 1C) , while the lowest correlation is found between testis and liver with a Spearman coefficient of 0.65 (Fig. 1D) .
Classification of the genes expressed in testis
The transcriptomics data obtained from the 27 tissues enabled us to classify all the 20 050 protein-encoding genes into four major categories based on their expression levels in testis ( Fig. 2A) . The major categories included (i) genes that were not detected in testis (23%), (ii) genes that showed a mixed expression pattern, being expressed in several, but not in all tissue types (21%), (iii) genes that were expressed in all tissues (46%) and (iv) genes that were categorized to have elevated levels of expression in testis when compared with the average expression levels in other tissue types (10%). The latter tissue-specific genes (n ¼ 1934) were further divided into four subcategories depending on degree of tissue specificity. Three hundred and sixty-four genes were defined as highly enriched in testis (Supplementary data, Table SIII), characterized as the highest level of tissue-specificity with at least 50-fold higher FPKM level in testis compared with any other tissue type. The top 50 highly enriched genes are displayed in Table I , with the tissuespecific score calculated as the ratio between the average FPKM in the seven testis tissues and the maximal FPKM in all the other tissues. Seven hundred and sixty genes in testis were defined as moderately enriched in testis (Supplementary data, Table SIV), with at least 5-fold higher FPKM level in testis compared with all other tissues and 254 genes were defined as group enriched (Supplementary data, Table SIV), with 5-fold higher average FPKM level in a group of 2 -7 tissues including testis compared with all other tissues. In addition, 556 genes were identified as testis enhanced (Supplementary data, Table SIV), defined as having a 5-fold higher FPKM level in testis when compared with the average FPKM value of all the 27 tissues.
From the transcriptomics analysis, it is possible to estimate the relative mRNA pool for each of the categories, as shown in Fig. 2B . Almost 80% of the transcripts in the testis correspond to genes with potential 'house-keeping' functions expressed also in all other tissues analyzed. This suggests that despite the highly specialized function of testis, most of the transcription apparatus is still devoted to 'house-hold' functions necessary for all types of cells (Fig. 2C , Supplementary data, Table SI ). An analysis of the testis-enriched genes shows that the mRNA pool constitutes 14% of the transcripts, with most of these corresponding to genes highly (6%) or moderately (5%) enriched in testis. The expression for all detected genes comparing the two samples of normal testis with the highest correlation (A) and the two individuals with lowest correlation (B). Similar analysis with a scatter plot showing the average FPKM values for the seven testis samples compared with the most similar other tissue type, ovary (C) and most dissimilar other tissue type, liver (D). Color code: not detected (grey), highly testis enriched, moderately testis enriched, group enriched or testis enhanced (blue), mixed (green), expressed in all, low (red), expressed in all, high (dark red). The correlation scores are given as pairwise Spearman's correlation coefficients between the respective individuals or tissues.
The human testis-specific proteome levels across the 27 analyzed tissues for the 30 most abundant highly enriched genes are shown in Fig. 2D and in Fig. 2E the top 30 groupenriched genes are shown. The shared expression of these groupenriched genes is distributed among the other tissues, but with a slight overrepresentation of shared genes with the brain.
The relation of the group-enriched genes is presented in a network plot in Fig. 3A , which shows the amount of genes shared with a particular tissue type (up to three different tissues). The tissue type with most group-enriched genes in common with testis is the brain (n ¼ 48), followed by lung (n ¼ 33), whereas the remaining 24 other tissue types only show a few group-enriched genes. A GO-based analysis of the group of enriched genes shared between testis and lung shows an enrichment for genes related to cilia function and movement. For the group-enriched genes shared between testis and brain there was no clear pattern of enriched GO-terms.
A GO-based analysis of all the 1124 genes identified as highly enriched (n ¼ 364) and moderately enriched (n ¼ 760) in the testis indicated a clear overrepresentation of genes associated with reproductive process (154 genes) and spermatogenesis (105 genes). The cellular localization of the corresponding proteins encoded by the highly and moderately testis enriched genes were distributed as intra-cellular (38%), membrane bound (5%) and extracellular (6%), whereas for half of the proteins (50%) the localization was unknown (Supplementary  data, Fig. S3A ).
Figure 2
Classification of all human protein-coding genes and gene expression levels for highly abundant, highly enriched and group-enriched genes in testis. Pie chart showing the distribution of gene expression comprising all 20 050 human putative protein-coding genes in testis (A). The pie chart is divided into four major categories based on the transcript abundance in analyzed tissues, including not detected in testis (grey), expressed in all tissues (red color shades), mixed expression with genes expressed in a large subset, but not all tissues (green) and genes with elevated expression in testis (blue color shades). The genes with elevated expression in testis are further subdivided dependent on the degree of specificity as highly testis-enriched genes (light blue), moderately enriched in testis (blue), group enriched in testis (darker blue) and genes enhanced in testis (dark blue). Pie chart displaying the distribution of mRNA molecules for the genes expressed in testis using the same color codes (B). Nearly 80% of all mRNA molecules are derived from housekeeping genes. The FPKM values are shown across all 27 different tissue types for the 30 genes with most abundant expression in the testis. Each color corresponds to a gene (C 
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The human testis-specific proteome
Cell type distribution of the testis specific genes
With the large amount of unknown genes based on the GO analysis, we further investigated how well characterized the 364 highly enriched genes in testis were by using gene summary information from Uniprot and NCBI data regarding function and the cell type specificity. Similar to the GO analysis, a large fraction (62%) of the highly enriched genes was not well characterized and only for 16% of the genes (n ¼ 60) the specific cell type expressing the gene was known (Fig. 3B) . The cell typespecific expression in relation to the different stages of the spermatogenesis of these previously known genes is shown in Supplementary data, Figure 3 Network plot of enriched genes, characterization of the highly enriched genes and cell type-specific expression for the 62 highly enriched genes previously not well characterized. Network plot of the testis-enriched genes showing the relation of group-enriched genes (A). The light blue circle shows the highly and moderately testis-enriched genes (n ¼ 1124). Dark blue nodes show the number of genes that are group enriched in two or three different tissue types (grey circles). The size of each blue node is related to the square root of the number of genes enriched in a particular combination of tissues. Pie chart based on the 364 highly testis-enriched genes, showing the distribution of preexisting knowledge with regard to function and cell types these genes are expressed in (B). Sixty-two percent of the highly testis-enriched genes are previously poorly characterized. Pie chart showing the cell type localization based on protein profiling using immunohistochemistry for 62 of the previously uncharacterized highly testis-enriched genes (C). Fig. S3B and Table SV . According to the analysis of previous literature, more than one-third of these genes (40%) were expressed in more than one cell type and of the cell type specifically expressed genes over half were expressed in the later stages of spermatogenesis, including spermatids (21%) and sperm (30%). Relatively few testis-specific genes have previously been identified as expressed in early stages of the spermatogenesis, in Sertoli or Leydig cells.
Antibody-based profiling of the testis
For the remaining highly enriched genes where cell type previously was unknown (n ¼ 305), the expression patterns were evaluated, for the corresponding proteins with available antibodies (n ¼ 260), using the online Human Protein Atlas (HPA) database. The HPA provides immunohistochemically stained TMA cores from 46 different normal human tissues, including three cores of human testicular tissue. The IHC staining was visually evaluated with regard to testis specificity and cellular distribution. The antibody-based profiling allows further determination of localization within different subcellular compartments and cell types within the testis, such as different morphologically defined stages during spermatogenesis, i.e. spermatogonia, spermatocytes, spermatids and sperm, and other testis specific cell types such as Sertoli cells and Leydig cells. The expression pattern for genes with fully congruent RNA-Seq and protein expression data (n ¼ 62) was analyzed in detail, and a large number of genes expressed in early phases of spermatogenesis were identified ( Fig. 3C and Supplementary data, Table SVI ). The protein expression pattern in testis corresponding to these highly testis-enriched genes are displayed in Supplementary data, Fig. S4 . Almost half of these genes showed expression in the earliest stages of spermatogenesis, including spermatogonia (38%) and spermatocytes (11%). Only a few genes were found to be localized to Sertoli cells and none of the highly enriched genes where cell type previously was unknown in testis was found to be expressed in Leydig cells.
Genes expressed in spermatogonia
Spermatogonia are diploid cells that form the basal layer of the seminiferous duct and present the initial phase of the spermatogenesis. The spermatogonia can be divided into two subtypes, type A cells that have stem cell-like properties and maintain the spermatogonia population and type B cells that produce primary spermatocytes. Both type A and B cells result from mitotic divisions (de Rooij and Russell 2000) . In Fig. 4A , five examples of proteins with specific expression in spermatogonia are shown as revealed by the immunohistochemistry analysis. Doublesex-and mab-3-related transcription factor 1 (DMRT1) encodes a protein that is described to primarily be expressed in the nuclei of spermatogonia (Jørgensen et al., 2012) . This transcription factor plays a key role in male sex determination and differentiation by controlling testis development and male germ cell proliferation (Matson et al., 2010) . Also PAS domain-containing 1 (PASD1), P antigen family member 1 (PAGE1) and DMRT-like family B with proline-rich C-terminal, 1 (DMRTB1) show nuclear expression restricted to spermatogonia located along the basement membrane of seminiferous ducts. The function of PAGE1 is unknown, but the PAGE1 gene belongs to a family of genes that has been described to be expressed in a variety of tumors, but with a testis restricted expression in normal tissues (cancer testis antigens) (Brinkmann et al., 1998) . For the PASD1 and DMRTB1 genes there is previously only evidence of existence at the transcript level.
The PASD1 gene encodes a putative protein with nuclear expression in spermatogonia. PASD1 is a proposed transcription factor and has also been classified as a cancer testis antigen (Liggins et al., 2004) . The DMRTB1 gene contains a DNA-binding domain but the putative protein is unknown with regard to function and expression pattern (Ottolenghi et al., 2002) . Expression of the putative protein encoded by chromosome 3 open reading frame 22 (C3ORF22) is also found in spermatogonia and shows a cytoplasmic expression pattern.
Genes expressed in spermatocytes
Spermatocytes, derived from type B spermatogonia, can be subdivided into primary spermatocytes that enter the first meiosis and secondary spermatocytes that enter the second meiosis to produce haploid spermatids. Several of the testis-specific proteins localized to spermatocytes were involved in testicular differentiation, proliferation and meiosis. Examples of proteins expressed in spermatocytes as revealed by the immunohistochemistry analysis are shown in Fig. 4B . The deleted-in-azoospermia-like (DAZL) gene encodes a well-known RNAbinding protein that is essential for gametogenesis in both males and females. In the testis, this protein is localized to the nucleus of spermatogonia, but relocates to the cytoplasm in spermatocytes during meiosis (Reijo et al., 2000) . The testis expressed 101 (TEX101) gene, has previously been reported to be associated with various phases of spermatogenesis, but more precise knowledge regarding the specific function and expression pattern is unknown (Teng et al., 2006) . Two additional examples of highly testis-enriched genes showing cytoplasmic expression predominantly in spermatocytes are the two cancer testis antigens transmembrane phosphatase with tensin homology (TPTE) (Tapparel et al., 2003) and fragile X mental retardation 1 neighbor (FMR1NB) with previously no information regarding what cell type in testis this gene is expressed in as well as the uncharacterized SHC SH2-domain binding protein 1-like (SHCBP1L) gene.
Genes expressed in spermatids
Spermatids are derived from secondary spermatocytes and these cells are subdivided into early, round spermatids that are transcriptionally active and late, elongated spermatids that are transcriptionally inert (Kierszenbaum and Tres, 1975) . The formation of the acrosome, a testisspecific organelle required for sperm-egg interactions, is formed during the meiotic development of the late spermatid into mature spermatozoa. The highly testis-enriched proteins with known function and predominant expression in spermatids are involved in conversion of nucleosomal chromatin and sperm development and maturation. Five examples of proteins showing expression in spermatids, including two proteins with expression restricted to the acrosome, are shown in Fig. 4C . The transition protein 1 (TNP1) gene encodes a spermatid-specific product of the haploid genome which replaces histone and is itself replaced in the mature sperm by the protamines. TNP1 protein is expressed in late stage, elongating spermatids and is involved in the conversion of nucleosomal chromatin to the compact, non-nucleosomal form found in the sperm nucleus (Wouters-Tyrou et al., 1998) . The proteins encoded by sperm mitochondria-associated cysteine-rich protein (SMCP) and actinlike protein 7B (ACTL7B) show a similar expression pattern in spermatids. SMCP encodes a sperm mitochondria-associated cysteine-rich protein that localizes to the capsule associated with the mitochondrial outer membranes and is thought to function in the organization and stabilization of the helical structure of the sperm's mitochondrial sheath (Hawthorne et al., 2006) . The ACTL7B gene, with evidence of existence at the transcript level, encodes a putative protein of unknown function that is suggested to be a member of a family of actin-related proteins which share significant amino acid sequence identity to conventional actins (Chadwick et al., 1999) . The two examples of proteins showing a distinct acrosomal expression pattern, include the well-characterized acrosomal vesicle protein 1 (ACRV1) and the uncharacterized transmembrane and coiled-coil domains 5A (TMCO5A) gene which only has evidence of existence at the transcript level. The ACRV1 gene encodes an acrosomal vesicle protein, which arises within the acrosomal vesicle during spermatogenesis, and is associated with the acrosomal membranes and matrix of mature sperm (Herr et al., 1990) . ACRV1 may be involved in binding or penetration of the oocyte zona pellucidum by the mature sperm.
Genes expressed in sperm
Following the maturation of late stage spermatids, the testicular end stage of spermatogenesis results in the formation of sperm. Sperm consists of uniflagellar sperm cells that are localized along the lumen of seminiferous ducts. Specific proteins localized to mature sperm are involved in functions including sperm motility and male fertility. Examples of proteins highly enriched in testis that are expressed in sperm are shown in Fig. 4D . The protamine 2 (PRM2) gene shows the highest expression level (2447 FPKM) of all the 364 highly testis-enriched genes (Wykes et al., 1995) . Protamines substitute for histones in sperm and represent the major DNA-binding proteins in sperm nuclei. The function of protamines is to package sperm DNA into a highly condensed, stable and inactive complex. The glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (GAPDHS) gene, with specific expression in the testis, has a similar function as the ubiquitously expressed GAPDH in regulating glycolysis. The encoded enzyme catalyzes an important energy-yielding step in carbohydrate metabolism and during spermatogenesis, this enzyme may play an important role in regulating the switch between different energy-producing pathways, required for sperm motility (Welch et al., 2000) The A kinase (PRKA) anchor protein 4 (AKAP4) gene encodes for a protein, suggested to be a major structural component of sperm fibrous sheath, which also plays a role in sperm motility (Turner et al., 2001) . The additional two examples include the chromosome 2 open reading frame 57 (C2orf 57) and chromosome 10 open reading frame 40 (C10orf40), both genes of unknown function and only evidence of existence at the transcript level.
Genes expressed in Sertoli and Leydig cells
The interaction between germinal cells and Sertoli cells is essential both for the development of testis and for the progress of the spermatogenesis (Griswold, 1998) . Of the highly testis-enriched genes in testis, only a few were specifically localized to Sertoli or Leydig cells when compared with the germ cell-specific proteins (Fig. 5) . The solute carrier organic anion transporter family, member 6A1 (SLCO6A1) with currently only evidence at transcript level has previously been reported to be strongly expressed in the human testis but not specifically in Sertoli cells. For the remaining examples of genes we found to be associated with Sertoli cells, the expression did not seem to be restricted to this particular cell type. For example, fetal and adult testis expressed (FATE1) protein is shown to be expressed in spermatogonia, primary spermatocytes and Sertoli cells which also has been reported previously (Yang et al., 2005) . Another example was defensin, beta 119 (DEFB119), a member of the betadefensin family assumed to be involved in antibacterial activity. The secreted DEFB119 protein, previously reported to be expressed in the testis and epididymis, showed an expression pattern suggesting that this protein also is expressed in Sertoli cells (Radhakrishnan et al., 2005) . Only one of the highly enriched genes in testis, the insulin-like 3 (Leydig cell) (INSL3) gene, showed specific expression in the androgenproducing Leydig cells. The INSL3 gene encodes a well-known marker of Leydig cells, suggested to be involved in the development of urogenital tract and intra-abdominal testicular descent (Burkhardt et al., 1994) .
Discussion
Here we demonstrate the power of combining genome-wide RNA and protein analysis to define the tissue-specific proteome of human testis. The analysis shows that 77% of all putative protein coding genes are expressed in the testis, which is more than in any of the other 26 tissues analyzed. In addition, the testis also has by far more tissue-enriched genes than any other human tissue with .1000 genes showing an at least 5-fold higher expression. One explanation to the large abundance of enriched genes in testis, when compared with other tissue types, could be that testis harbors the only male cell type that undergoes meiosis to generate haploid cells. Meiosis involves several specific events such as reduction of the number of chromosomes, condensation of nucleus and removal of excess cytoplasm within the sperm. In addition, the sperm cells can be described as an independent unicellular organism that has acquired unique morphological features and structures that are necessary for sperm motility and fertilization of the egg. It is not unlikely that many of the genes here identified as testis specific could show shared expression with the cells developing into the haploid egg in females. An important extension of this could therefore be to include additional specialized tissue types from females including an enrichment of oocytes. More work is needed to explore the expression pattern of the development of the egg in females to establish the differences between the development of the haploid cell in males and females. It is noteworthy that the term "testis specific" is used for the genes with enriched or enhanced expression in testis, but in reality a vast majority of these genes have transcripts present also in other tissues. A tissuespecific score has therefore been obtained for all genes to define the ratio of mRNA levels in testis when compared with the maximum mRNA levels in all other tissues. In this analysis we have focused on the highly enriched genes with a ratio over 50 and found that most of these were expressed in germ cells of the seminiferous epithelium, whereas the two somatic cell types in testis, Leydig and Sertoli cells, only expressed a few highly enriched genes. This supports the assumption that the cell types specifically involved in spermatogenesis account for the large amount of specific genes. It is therefore likely that the expression profiles of Sertoli and Leydig cells more resemble other somatic cell types and hence do not contain as many specific genes as germ cells. For example, suggested Sertoli cell markers such as the anti-Mullerian hormone (AMH) (Josso et al., 1977) was also expressed in the brain, the follicle-stimulating hormone receptor (Heckert and Griswold, 2002) was expressed in the ovary and the inhibin alpha (Merchenthaler et al., 1987) was expressed in the adrenal gland, ovary and placenta and accordingly these genes were categorized as group enriched or enhanced in testis. It should also be pointed out that genes with low levels of expression may still exist with a specific expression in Sertoli or Leydig cells, but given that 90% of the mRNA from testicular tissue is derived from germ cells, such genes may not readily be detected. A more in-depth analysis of the testis genes detected in the categories moderately enriched, group enriched and enhanced would be of interest to generate a more complete view of expression patterns in testicular tissue.
Altogether the tissue-specific genes, including testis-enriched, groupenriched and testis-enhanced genes, constitute 10% of all the human genes and 14% of the transcript pool. An analysis of the most expressed genes in testis also support that few of the testis-specific genes are expressed at high mRNA levels. Despite the high number of tissuespecific genes in testis, an in-depth analysis of the mRNA pool derived from testicular tissue demonstrates that 80% of the transcripts are encoded by genes expressed in all 27 tissues ('house-keeping') (Fagerberg et al., 2014) , well consistent with that a large fraction of all expressed proteins is shared between different tissues (Pontén et al., 2009) . The list of all these genes with elevated expression in testis can be downloaded from the Human Protein Atlas portal (www.proteinatlas.org) and are also provided as Supplementary data, Table SIV .
An interesting category of proteins is the genes with shared elevated expression with at least another tissue (group enriched). The network analysis demonstrates that the tissues with most shared tissue-enriched genes are the brain (n ¼ 48) and the lung (n ¼ 33). A functional analysis shows that several of the genes shared with the lung are involved in functions involving motility of cilia and sperm, while the genes shared with the brain show less enrichment for any specific functions. A subset of genes expressed in the testis and brain are RNA-binding proteins evidently involved in the regulation of transcription and another subset are expressed during development, such as the AMH gene that encodes a growth factor involved in male sexual differentiation by causing the regression of Mullerian ducts.
It has earlier been suggested that tissue-specific genes are overrepresented for genes coding for secreted and transmembrane spanning proteins, summarized as the inside -outside rule (Ramskö ld et al., 2009; Fagerberg et al., 2010) . In contrast, the analysis of the testis-specific proteins shows that a large majority (76%) of the tissue-specific genes with known subcellular localization are intracellular. This suggests that the inside -outside rule for tissue specificity does not apply for the testis and that most of the testis-specific functions are expressed inside the cell which is not surprising since meiosis, histone replacement and sperm differentiation mainly reflect intracellular events.
Combining the data from previously well-characterized testis-specific proteins with present data regarding subcompartment localization in testis suggests that approximately half of the testis-specific genes are expressed in late stage spermatogenesis, sperm (30%) and spermatids (21%), whereas only a few are expressed in earlier stages, spermatogonia (3%) and spermatocytes (4%). Interestingly, a majority of the genes analyzed here with previous unknown knowledge regarding cell-type localization were expressed in early stage spermatogenesis. A substantial subset of these proteins belong to the family of cancer testis antigens. At present .100 cancer testis antigens genes have been identified and a similar study including data from cancer tissues could be of interest to identify additional cancer testis antigens. These genes are important since they are restricted to germ cells in normal tissues, but frequently expressed in various cancer tissues. In addition, the corresponding proteins appear immunogenic and recognized by the immune system of cancer patients and thus believed to be of use in the development of antigen-specific cancer vaccines (van der Bruggen et al., 1991; Chen et al., 1997) .
In conclusion, the analysis has identified genes of interest to study testis biology. These genes are interesting starting points for studying mechanisms for infertility and basic cell biology. In this work we have focused our protein analysis on genes with corresponding unambiguously staining antibodies and further analysis is needed for the identified testis-specific genes not yet characterized on the protein level. The ultimate aim of such an effort should be to provide a complete map of expression patterns of all genes expressed in a tissue-specific manner.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/.
